For Your Consideration... The case for cannabinoid CB1 receptors as a target for bronchodilator therapy for β-agonist resistant asthma. Curr Drug Targets. 2017 Jun 15. doi: 10.2174/1389450118666170615101220. Ashton J1, Hancox RJ2. Author information Abstract…Freedom WaresJune 15, 2017
